FindTrial
Sign In

Comparison of effectiveness and patient tolerance of two doses (single and split) of a bowel preparation agent (polyethylene glycol)for bowel preparation for colonoscopy (looking at large bowel with an endoscope)in children

Efficacy and tolerability of single dose versus split dose Polyethylene glycol for colonic preparation in children: Randomized control study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/08/009303
Enrollment
176
Registered
2017-08-08
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- : Consecutive children (between 1- 18 years of age) who are going to have colonoscopy Health Condition 2: K928- Other specified diseases of the digestive system

Interventions

Intervention1: Polyethylene glycol (PEG) laxative single dose for bowel preparation before colonoscopy: Consecutive patient full filling the inclusion criteria and planned for colonoscopy will be enr

Sponsors

Sanjay Gandhi Post Graduate Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 1-18 years Either sex Elective colonoscopy: both diagnostic and therapeutic Consent given

Exclusion criteria

Exclusion criteria: Age Known allergy to PEG Known electrolyte disturbances Known metabolic , renal or cardiac disease Emergency colonoscopy Consent not given

Design outcomes

Primary

MeasureTime frame
Adequacy of colonic preparation with single versus split dose of polyethylene glycol.Timepoint: At the time of colonoscopy—

Secondary

MeasureTime frame
To compare the tolerability and side effects (if any) of two different doses of polyethylene glycolTimepoint: At the end of preparation and before colonoscopy—

Countries

India

Contacts

Public ContactUjjal Poddar

Sanjay Gandhi Post Graduate Institute of Medical Sciences

parijattripathi1986@gmail.com05222495367

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026